John Sheridan Insider Profile

4 Followers
John Sheridan, PRESIDENT & CEO, Director at Tandem Diabetes Care, holds 14.98K shares in Tandem Diabetes Care (Ticker: TNDM), holds 15.95K shares in Acutus Medical (Ticker: AFIB), holds 7.56K shares in Volcano Corp (Ticker: VOLC).
John Sheridan

John Sheridan
Tandem Diabetes Care (TNDM)
PRESIDENT & CEO, Director

Ranked #61,864 out of 103,103 Corporate Insiders

Profitable Transactions

43%
3 out of 7 Profitable Transactions

Average Return

-4.20%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark

Insider Holdings

$643K
98.06%
1.94%
A breakdown of John Sheridan's holdings

Insider Roles

Tandem Diabetes Care
(TNDM)
PRESIDENT & CEO, Director
Acutus Medical
(AFIB)
Director
Roles that John Sheridan holds in companies

Most Profitable Insider Trade

Stock:
Tandem Diabetes Care
(TNDM)
Rating:Informative Sell
Date:Aug 03, 2016 - Aug 03, 2017
Return:+93.50%
The most profitable trade made by John Sheridan

John Sheridan's Trading History

Company Name
Last Transaction Date
Insider Position
Last Transaction
Last Transaction Amount
Holding Value
Tandem Diabetes Care
Mar 01, 2023
PRESIDENT & CEO, Director
Uninformative Sell
$11.05K
$630.77K
Acutus Medical
Jun 21, 2022
Director
Uninformative Buy
$12.45K
VOLC
Volcano Corp
Feb 05, 2010
Uninformative Buy
$45.54K
List of latest transactions for each holding click on a transaction to see John Sheridan's performance on stock

John Sheridan insider profile FAQ

What is the percentage of profitable transactions made by John Sheridan?
The percentage of profitable transactions made by John Sheridan is 43%.
    What is the average return per transaction made by John Sheridan?
    The average return per transaction made by John Sheridan is -4.20%.
      What stocks does John Sheridan hold?
      John Sheridan holds: TNDM, AFIB, VOLC stocks.
        What was John Sheridan’s latest transaction?
        John Sheridan latest transaction was an Uninformative Sell of $11.05K.
          What was John Sheridan's most profitable transaction?
          John Sheridan’s most profitable transaction was an Informative Sell of TNDM stock on August 3, 2016. The return on the trade was 93.50%.
            What is John Sheridan's role in Tandem Diabetes Care?
            John Sheridan's role in Tandem Diabetes Care is PRESIDENT & CEO, Director.
              How can I follow the stock ratings of top corporate insiders?
              Head over to our Expert Center to see a list of the Top 100 corporate insiders and follow the corporate insiders of your choice. Visit their profiles for more details about their stock transactions and see how they perform on a stock-by-stock basis.